Clostridium difficile Is Associated With Poor Outcomes in Patients With Cirrhosis: A National and Tertiary Center Perspective

被引:139
作者
Bajaj, Jasmohan S. [1 ,2 ]
Ananthakrishnan, Ashwin N. [3 ]
Hafeezullah, Muhammad [3 ]
Zadvornova, Yelena [3 ]
Dye, Alexis [4 ]
McGinley, Emily L. [4 ]
Saeian, Kia [3 ]
Heuman, Douglas [1 ,2 ]
Sanyal, Arun J. [1 ,2 ]
Hoffmann, Raymond G. [5 ]
机构
[1] Virginia Commonwealth Univ, Div Gastroenterol Hepatol & Nutr, Dept Med, Richmond, VA 23249 USA
[2] McGuire VA Med Ctr, Richmond, VA 23249 USA
[3] Med Coll Wisconsin, Dept Med, Div Gastroenterol & Hepatol, Milwaukee, WI 53226 USA
[4] Med Coll Wisconsin, Dept Populat Hlth, Milwaukee, WI 53226 USA
[5] Med Coll Wisconsin, Dept Pediat, Div Biostat, Milwaukee, WI 53226 USA
关键词
SPONTANEOUS BACTERIAL PERITONITIS; PROTON PUMP INHIBITORS; INFECTIONS; PROPHYLAXIS; ICD-9-CM; FAILURE; DISEASE; IMPACT; RISK;
D O I
10.1038/ajg.2009.615
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
OBJECTIVES: Clostridium difficile-associated disease ( CDAD) is associated with antibiotic use, acid suppression, and hospitalization, all of which occur frequently in cirrhosis. The aim was to define the effect of CDAD on outcomes and identify risk factors for its development in cirrhosis. METHODS: Case-control studies using the de-identified national (Nationwide Inpatient Sample, NIS) and an identified liver transplant center database of hospitalized cirrhotics with and without CDAD were performed. The NIS 2005 was queried for mortality, charges, and length of stay (LOS) in cirrhotics with/without CDAD. Outcomes of cirrhosis and infections were also analyzed. In the transplant center database, risk factors for CDAD were defined in hospitalized cirrhotics with/without CDAD who were age matched in a 1:2 ratio. RESULTS: The NIS 2005 included 1,165 cirrhotics with and 82,065 without CDAD. Cirrhotics with CDAD had a significantly higher mortality (13.8% vs. 8.2%, P<0.001), LOS (14.4 days vs. 6.7 days, P<0.001), and charges ($79,351 vs. $35,686, P<0.001) compared with those without CDAD. On multivariate analysis, CDAD was associated with higher mortality (odds ratio (OR) 1.55, 95% confidence interval (CI) 1.29-1.85), charges, and LOS despite controlling for cirrhosis complications and infections. In the transplant center database, 54 cirrhotics with and 108 cirrhotics without CDAD were included. Outpatient spontaneous bacterial peritonitis prophylaxis (35% vs. 13%, P = 0.01), inpatient antibiotic (63% vs. 35%, P = 0.0001), and proton pump inhibitor (PPI) use (74% vs. 31%, P = 0.0001) were significantly higher in those with CDAD. CONCLUSIONS: Cirrhotics with CDAD have a higher mortality, LOS, and charges on the NIS 2005 compared with those without CDAD. Antibiotic and PPI use are risk factors for CDAD development in hospitalized cirrhotics. Am J Gastroenterol 2010; 105: 106-113; doi:10.1038/ajg.2009.615; published online 20 October 2009
引用
收藏
页码:106 / 113
页数:8
相关论文
共 29 条
[1]   Omeprazole inhibits phagocytosis and acidification of phagolysosomes of normal human neutrophils in vitro [J].
Agastya, G ;
West, BC ;
Callahan, JM .
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2000, 22 (02) :357-372
[2]   Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease [J].
Ananthakrishnan, A. N. ;
McGinley, E. L. ;
Binion, D. G. .
GUT, 2008, 57 (02) :205-210
[3]   Gastric Acid Suppression by Proton Pump Inhibitors as a Risk Factor for Clostridium difficile-Associated Diarrhea in Hospitalized Patients [J].
Aseeri, Mohammed ;
Schroeder, Todd ;
Kramer, Joan ;
Zackula, Rosalee .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 (09) :2308-2313
[4]   Association of Proton Pump Inhibitor Therapy With Spontaneous Bacterial Peritonitis in Cirrhotic Patients With Ascites [J].
Bajaj, Jasmohan S. ;
Zadvornova, Yelena ;
Heuman, Douglas M. ;
Hafeezullah, Muhammad ;
Hoffmann, Raymond G. ;
Sanyal, Arun J. ;
Saeian, Kia .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2009, 104 (05) :1130-1134
[5]   The challenges posed by reemerging Clostridium difficile infection [J].
Blossom, David B. ;
McDonald, L. Clifford .
CLINICAL INFECTIOUS DISEASES, 2007, 45 (02) :222-227
[6]   Infection in solid-organ transplant recipients [J].
Cross, Timothy J. S. ;
Berry, Phillip A. ;
Burroughs, Andrew K. .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (12) :1302-1302
[7]  
Cunningham R, 2008, J HOSP INFECT, V70, P1, DOI 10.1016/j.jhin.2008.04.023
[8]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[9]   Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease [J].
Dial, S ;
Delaney, JAC ;
Barkun, AN ;
Suissa, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (23) :2989-2995
[10]   ICD-9 codes and surveillance for Clostridium difficile-associated disease [J].
Dubberke, Erik R. ;
Reske, Kimberly A. ;
McDonald, L. Clifford ;
Fraser, Victoria J. .
EMERGING INFECTIOUS DISEASES, 2006, 12 (10) :1576-1579